Bedminster-based Aerie Pharmaceuticals Inc. announced Monday it has registered with the Securities and Exchange Commission for an initial public offering. The offering will consist of common stock.
According to the announcement, the number of shares to be offered and the price range for the offering have not been determined. RBC Capital Markets and Stifel will serve as joint book-running managers for the offering. Lazard Capital Markets and Canaccord Genuity will serve as co-managers.